期刊文献+

一期前路病灶清除植骨融合钛板固定治疗颈椎结核

One-stage Surgical Treatment of Cervical Spinal Tuberculosis ment, Iiiac Grafting and Internal Fixation
下载PDF
导出
摘要 【目的】评价一期前路病灶清除植骨融合钛板固定在治疗颈椎结核中的临床疗效。【方法】2004年2月至2008年2月对32例颈椎结核患者采用一期前路病灶清除,植骨融合钛板固定术,术前2~3周抗痨、术后正规抗痨治疗9~12个月。术后随访时间14个月至3年,平均时间为19个月,回顾分析手术适应证,术后症状改善、远期疗效及并发症情况。【结果】所有患者疼痛症状均消除,无一例出现感染和复发,结核治愈率为100%;术后6个月时骨性融合率达50%,12个月时达100%,椎体高度恢复1.1~2.1cm,平均1.4cm,cobb's角平均纠正20°。【结论】一期前路病灶清除植骨融合钛板固定治疗颈椎结核具有减压彻底、神经功能恢复良好、重建可靠和复发率低等优点。 [Objective]To evaluate the efficacy of anterior radical debridement, iliac grafting and internal fixation for treating cervical spinal tuberculosis. [Methods] From Feb. 2004 to Feb. 2008, 32 patients were operated with anterior radical debridement, iliac grafting and internal fixation. These patients carried out regular anti-tuberculosis plan both before and after operations. During the follow-up from 14 to 36 months (an average of 19 months), complication and neurological function were assessed. [Results] All patients had no painful symptoms. Recurrence and affection were not found in all patients, and the cure rate was 100%. The bone fusion rate at 6 and 12 months after operation was 50% and 100%, respectively. The height of the verte brae recovered was from 2. lcm to 2. 1cm with an average of 1.4cm, and the cobb's angle corrected was 20°at average. [Conclusion]One-stage surgical operation with anterior radical debridement, iliac grafting and inter nal fixation is an effective for the treatment of fervical spinal tuberculosis. It has advantages of complete decompression, good neurological function recovery, stable reconstruction and low recurrence rate, etc.
出处 《医学临床研究》 CAS 2009年第12期2306-2308,共3页 Journal of Clinical Research
关键词 结核 脊柱/外科学 颈椎/外科学 脊柱融合术 tuberculosis, spinal/SU cervical vertebrae/SU spinal fusion titanium
  • 相关文献

参考文献5

二级参考文献27

  • 1何建荣,杨子斌,王正祥,杨春艳,洪建斌.脊柱结核手术中的内固定应用及术式选择[J].临床骨科杂志,2004,7(3):274-276. 被引量:15
  • 2张宏其,龙文荣,邓展生,郭超峰,胡建中,林涨源,何洪波,吴建煌,李康华,廖前德.影响一期手术治疗脊柱结核并截瘫患者疗效的相关因素[J].中国脊柱脊髓杂志,2004,14(12):720-723. 被引量:37
  • 3李家泰主编.临床药理学(第2版)[M].北京:人民卫生出版社,1997.492-700.
  • 4Yilmaz C, Selek H,Gtirkan I,et al.Anterior instrumentation for the treatment of spinal tuberculosis[J].J Bone Joint Surg (Am),1999,81-A(9):1261-1267.
  • 5An YH,Friedman RJ.Concise review of mechanisms of bacterial adhesion to biomaterial surfaces [J].J Biomed Mater Res,1998,43(3):338-348.
  • 6Tuli SM, Kumar K, Sen PC. Penetration of antitubercular drugs in clinical osteoarticular tubercular lesions. Acta Orthop Scand. 1977,48: 362-368.
  • 7Panchagnula R, Sood A, Sharda N, et al..Determination of rifampicin and its main metabolite in plasma and urine in presence of pyrazinamide and isoniazid by HPLC method. J Pharm Biomed Anal, 1999,18: 1013-1020.
  • 8Jain R, Sawhney S, Berry M. Computed tomography of vertebral tuberculosis: panerns of bone destruction. Clin Radiol, 1993, 47:196-199.
  • 9Roncoroni A J, Manuel C, Nedjar C, et al. Cefamandole bone diffusion in patients undergoing total hip replacement. Chemotherapy,1981, 27: 166-172.
  • 10Both B. Penertration of parenterally administered rifampicin into bone tissue. Chemotherapy, 1984, 30: 358-365.

共引文献170

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部